Joseph C. Wu

Joseph C. Wu is an American physician-scientist and a leading figure in cardiovascular medicine and stem cell biology. He is the Director of the Stanford Cardiovascular Institute and the Simon H. Stertzer, MD, Professor of Medicine and Radiology at the Stanford University School of Medicine. His pioneering work focuses on using patient-derived induced pluripotent stem cells to model heart disease, develop new therapies, and advance the field of precision medicine.

Biography

Joseph C. Wu earned his undergraduate degree in Molecular biophysics and biochemistry from Yale University before completing both an M.D. and a Ph.D. in Molecular pharmacology at the University of California, Los Angeles (UCLA). He completed his clinical training in internal medicine at Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School, followed by fellowships in cardiovascular medicine and nuclear cardiology at the UCLA Medical Center. He joined the faculty at Stanford University in 2007, where he has since held several leadership positions, including Director of the Stanford Cardiovascular Institute. His career trajectory has been marked by a consistent integration of basic stem cell research with clinical applications in cardiology.

Research and career

Wu's research program is internationally recognized for its innovative use of induced pluripotent stem cell (iPSC) technology to create patient-specific models of human disease. His laboratory was among the first to generate functional cardiomyocytes from human iPSCs and to use these cells to model inherited cardiac conditions like Long QT syndrome and Dilated cardiomyopathy. This work provides a powerful platform for studying disease mechanisms, screening for new drugs, and assessing cardiotoxicity of pharmaceuticals, contributing significantly to the fields of drug discovery and personalized medicine. A major thrust of his current research involves using genome editing tools like CRISPR-Cas9 to correct disease-causing mutations in iPSCs and employing artificial intelligence to analyze complex cellular and imaging data. His team also investigates stem cell-based regenerative medicine strategies for repairing damaged heart tissue following events like myocardial infarction.

Awards and honors

Throughout his career, Joseph C. Wu has received numerous prestigious awards recognizing his scientific contributions. These include the American Heart Association's Merit Award, the National Institutes of Health Director's Pioneer Award, and the Distinguished Scientist Award from the American College of Cardiology. He is an elected member of the Association of American Physicians and the American Society for Clinical Investigation, honors reserved for physician-scientists who have made significant contributions to medical science. His research has been consistently funded by major institutions such as the National Heart, Lung, and Blood Institute and the California Institute for Regenerative Medicine.

Selected publications

Wu has authored hundreds of peer-reviewed articles in high-impact journals. Selected key publications include foundational papers in *Nature* and *Cell* on the derivation and applications of iPSC-derived cardiomyocytes. His work has been published in leading periodicals such as *Science Translational Medicine*, *Cell Stem Cell*, *Circulation*, and the *Journal of the American College of Cardiology*. These publications span topics from the basic biology of cardiac differentiation and disease modeling to translational studies on drug screening and the bioengineering of cardiac tissue patches for therapeutic implantation.

Category:American cardiologists Category:Stem cell researchers Category:Stanford University faculty